Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Cash (2020 - 2025)

Historic Change in Cash for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $241.6 million.

  • Roivant Sciences' Change in Cash rose 10531.15% to $241.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.8 billion, marking a year-over-year decrease of 4190.94%. This contributed to the annual value of -$3.8 billion for FY2025, which is 17872.63% down from last year.
  • Per Roivant Sciences' latest filing, its Change in Cash stood at $241.6 million for Q4 2025, which was up 10531.15% from -$1.4 million recorded in Q3 2025.
  • Over the past 5 years, Roivant Sciences' Change in Cash peaked at $5.0 billion during Q4 2023, and registered a low of -$4.5 billion during Q4 2024.
  • Moreover, its 5-year median value for Change in Cash was -$133.3 million (2021), whereas its average is -$408.4 million.
  • Per our database at Business Quant, Roivant Sciences' Change in Cash soared by 103684.26% in 2023 and then plummeted by 1374894.56% in 2024.
  • Over the past 5 years, Roivant Sciences' Change in Cash (Quarter) stood at $84.5 million in 2021, then crashed by 731.07% to -$533.0 million in 2022, then skyrocketed by 1036.84% to $5.0 billion in 2023, then plummeted by 191.1% to -$4.5 billion in 2024, then surged by 105.31% to $241.6 million in 2025.
  • Its last three reported values are $241.6 million in Q4 2025, -$1.4 million for Q3 2025, and -$1.5 billion during Q2 2025.